VYKOURA Drug Patent Profile
Which patents cover Vykoura, and when can generic versions of Vykoura launch?
Vykoura is a drug marketed by Avyxa Holdings and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in VYKOURA is leucovorin calcium. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vykoura
A generic version of VYKOURA was approved as leucovorin calcium by HIKMA on September 14th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VYKOURA?
- What are the global sales for VYKOURA?
- What is Average Wholesale Price for VYKOURA?
Summary for VYKOURA
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Patent Applications: | 6,504 |
| What excipients (inactive ingredients) are in VYKOURA? | VYKOURA excipients list |
| DailyMed Link: | VYKOURA at DailyMed |
Pharmacology for VYKOURA
| Drug Class | Folate Analog |
US Patents and Regulatory Information for VYKOURA
VYKOURA is protected by one US patents.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avyxa Holdings | VYKOURA | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 220406-001 | Feb 3, 2026 | RX | Yes | Yes | 12,564,592 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Avyxa Holdings | VYKOURA | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 220406-002 | Feb 3, 2026 | RX | Yes | Yes | 12,564,592 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Avyxa Holdings | VYKOURA | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 220406-003 | Feb 3, 2026 | RX | Yes | Yes | 12,564,592 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
